+4.4% · 90d
$30.64
-0.94 (-2.98%)
After-Hours $30.64(+0.00)
News
(1)April 2026
EWTX shares proxy details annual votes for directors and compensation
EWTXEdgewise Therapeutics, Inc.
# 🧾 What This Document Is — Your Company Playbook for the Annual Vote This is a **DEF 14A**, also known as a **Proxy Statement**. Think of it as a detailed invitation and guidebook for Edgewise Therapeutics' shareholders. Its main job is to give you all the information you need to vote on importan
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%